Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
ADNOC Gas Targets Up to $4B Profit in 2026 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
NORWOOD, Mass., Feb. 22, 2018 -- Xcerra (Nasdaq:XCRA) and Hubei Xinyan Equity Investment Partnership today announced that they have mutually agreed to withdraw their joint voluntary filing to the Committee on Foreign Investment in the United States (CFIUS) in relation to their proposed transaction and have terminated their merger agreement.
“We believe that our transaction with Xinyan was in the best interests of our shareholders, our customers, and our employees. Despite our best efforts to secure approval, it has become evident that CFIUS will not clear this transaction and we and Xinyan have mutually decided to terminate our merger agreement,” said Dave Tacelli, president and CEO of Xcerra Corporation.
“Xcerra is a strong and well-positioned company. The business environment remains robust for all of our semiconductor test products and bare-board flying probe test systems, and we will continue to innovate and unlock opportunities for the business in existing and new markets.”
“Our transaction with Xinyan was about enabling Xcerra to accelerate its growth in the China market as well as broadening and strengthening our customer relationships around the world. While we are disappointed that we were not able to receive approval from CFIUS on this transaction, Xcerra and Xinyan are discussing alternatives to pursue opportunities in new and existing markets in China.”
About Xcerra
Xcerra Corporation is comprised of four powerful brands in the semiconductor and electronics manufacturing test markets: atg-Luther & Maelzer, Everett Charles Technologies, LTX-Credence and Multitest. The combination of these businesses creates a Company with a broad spectrum of semiconductor and PCB test expertise that drive innovative new products and services, and the ability to deliver to customers fully integrated semiconductor test cell solutions. The Company addresses the broad, divergent requirements of the mobility, industrial, automotive and consumer end markets, offering a comprehensive portfolio of solutions and technologies, and a global network of strategically deployed applications and support resources. Additional information can be found at www.xcerra.com or at each product group’s website; www.atg-lm.com, www.ectinfo.com, www.ltxc.com and www.multitest.com.
Investor Contact:
Richard Yerganian,
Vice President, Investor Relations
Xcerra Corporation
Tel. 781.467.5063
Email: [email protected]
Media Contact:
Anthony Applewhaite
Director
Brunswick Group
Tel. 202.393.7337
Email: [email protected]
Xcerra is a trademark of Xcerra Corporation.
All other trademarks are the property of their respective owners.
